Assessing and Optimizing Large Language Models on Spondyloarthritis Multi-Choice Question Answering: Protocol for Enhancement and Assessment
- PMID: 38788208
- PMCID: PMC11161706
- DOI: 10.2196/57001
Assessing and Optimizing Large Language Models on Spondyloarthritis Multi-Choice Question Answering: Protocol for Enhancement and Assessment
Abstract
Background: Spondyloarthritis (SpA), a chronic inflammatory disorder, predominantly impacts the sacroiliac joints and spine, significantly escalating the risk of disability. SpA's complexity, as evidenced by its diverse clinical presentations and symptoms that often mimic other diseases, presents substantial challenges in its accurate diagnosis and differentiation. This complexity becomes even more pronounced in nonspecialist health care environments due to limited resources, resulting in delayed referrals, increased misdiagnosis rates, and exacerbated disability outcomes for patients with SpA. The emergence of large language models (LLMs) in medical diagnostics introduces a revolutionary potential to overcome these diagnostic hurdles. Despite recent advancements in artificial intelligence and LLMs demonstrating effectiveness in diagnosing and treating various diseases, their application in SpA remains underdeveloped. Currently, there is a notable absence of SpA-specific LLMs and an established benchmark for assessing the performance of such models in this particular field.
Objective: Our objective is to develop a foundational medical model, creating a comprehensive evaluation benchmark tailored to the essential medical knowledge of SpA and its unique diagnostic and treatment protocols. The model, post-pretraining, will be subject to further enhancement through supervised fine-tuning. It is projected to significantly aid physicians in SpA diagnosis and treatment, especially in settings with limited access to specialized care. Furthermore, this initiative is poised to promote early and accurate SpA detection at the primary care level, thereby diminishing the risks associated with delayed or incorrect diagnoses.
Methods: A rigorous benchmark, comprising 222 meticulously formulated multiple-choice questions on SpA, will be established and developed. These questions will be extensively revised to ensure their suitability for accurately evaluating LLMs' performance in real-world diagnostic and therapeutic scenarios. Our methodology involves selecting and refining top foundational models using public data sets. The best-performing model in our benchmark will undergo further training. Subsequently, more than 80,000 real-world inpatient and outpatient cases from hospitals will enhance LLM training, incorporating techniques such as supervised fine-tuning and low-rank adaptation. We will rigorously assess the models' generated responses for accuracy and evaluate their reasoning processes using the metrics of fluency, relevance, completeness, and medical proficiency.
Results: Development of the model is progressing, with significant enhancements anticipated by early 2024. The benchmark, along with the results of evaluations, is expected to be released in the second quarter of 2024.
Conclusions: Our trained model aims to capitalize on the capabilities of LLMs in analyzing complex clinical data, thereby enabling precise detection, diagnosis, and treatment of SpA. This innovation is anticipated to play a vital role in diminishing the disabilities arising from delayed or incorrect SpA diagnoses. By promoting this model across diverse health care settings, we anticipate a significant improvement in SpA management, culminating in enhanced patient outcomes and a reduced overall burden of the disease.
International registered report identifier (irrid): DERR1-10.2196/57001.
Keywords: AI; AI chatbot; AI-assistant diagnosis; artificial intelligence; benchmark; large language model; spondyloarthritis.
©Anan Wang, Yunong Wu, Xiaojian Ji, Xiangyang Wang, Jiawen Hu, Fazhan Zhang, Zhanchao Zhang, Dong Pu, Lulu Tang, Shikui Ma, Qiang Liu, Jing Dong, Kunlun He, Kunpeng Li, Da Teng, Tao Li. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 24.05.2024.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures





References
-
- Bommasani R, Hudson DA, Adeli E, Altman R, Arora S, von Arx S, Bernstein MS, Bohg J, Bosselut A, Brunskill E, Brynjolfsson E, Buch S, Card D, Castellon R, Chatterji N, Chen A, Creel K, Davis JQ, Demszky D, Donahue C, Doumbouya M, Durmus E, Ermon S, Etchemendy J, Ethayarajh K, Fei-Fei L, Finn C, Gale T, Gillespie L, Goel K, Goodman N, Grossman S, Guha N, Hashimoto T, Henderson P, Hewitt J, Ho DE, Hong J, Hsu K, Huang J, Icard T, Jain S, Jurafsky D, Kalluri P, Karamcheti S, Keeling G, Khani F, Khattab O, Koh PW, Krass M, Krishna R, Kuditipudi R, Kumar A, Ladhak F, Lee M, Lee T, Leskovec J, Levent I, Li XL, Li X, Ma T, Malik A, Manning CD, Mirchandani S, Mitchell E, Munyikwa Z, Nair S, Narayan A, Narayanan D, Newman B, Nie A, Niebles JC, Nilforoshan H, Nyarko J, Ogut G, Orr L, Papadimitriou I, Park JS, Piech C, Portelance E, Potts C, Raghunathan A, Reich R, Ren H, Rong F, Roohani Y, Ruiz C, Ryan J, Ré C, Sadigh D, Sagawa S, Santhanam K, Shih A, Srinivasan K, Tamkin A, Taori R, Thomas AW, Tramèr F, Wang RE, Wang W, Wu B, Wu J, Wu Y, Xie SM, Yasunaga M, You J, Zaharia M, Zhang M, Zhang T, Zhang X, Zhang Y, Zheng L, Zhou K, Liang P. On the opportunities and risks of foundation models. arXiv. doi: 10.48550/arXiv.2108.07258. Preprint posted online on July 12, 2022. https://arxiv.org/abs/2108.07258 - DOI
-
- Kraljevic Z, Bean D, Shek A, Bendayan R, Hemingway H, Yeung JA, Deng A, Baston A, Ross J, Idowu E, Teo JT, Dobson RJB. Foresight—a generative pretrained transformer for modelling of patient timelines using electronic health records: a retrospective modelling study. Lancet Digit Health. 2024 Apr;6(4):e281–e290. doi: 10.1016/s2589-7500(24)00025-6. https://arxiv.org/abs/2212.08072 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources